Literature DB >> 4397078

Clinical and radiologic improvement of regional enteritis and enterocolitis after treatment with salicylazosulfapyridine.

F Goldstein, M G Murdock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4397078     DOI: 10.1007/bf02235087

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  5 in total

1.  Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES; F A JONES
Journal:  Lancet       Date:  1962-05-26       Impact factor: 79.321

2.  Regional enteritis: an evaluation of the present-day therapeutic management.

Authors:  J A BARGEN
Journal:  Ann Intern Med       Date:  1957-11       Impact factor: 25.391

3.  Reversibility of radiological appearances during clinical improvement in colonic Crohn's disease.

Authors:  J H Jones; J E Lennard-Jones; A C Young
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

4.  Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.

Authors:  E M Cooke
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

5.  Azathioprine for Crohn's disease.

Authors:  B N Brooke; D C Hoffmann; E T Swarbrick
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

  5 in total
  3 in total

1.  Editorial: Sulphasalazine for Crohn's diseases?

Authors: 
Journal:  Br Med J       Date:  1975-05-10

2.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

Review 3.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.